Related Experiment Video
Updated: Aug 1, 2025

Bacteriophage Effectiveness for Biocontrol of Foodborne Pathogens Evaluated via High-Throughput Settings
Published on: August 19, 2021
Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria
He Liu1, Zhen Hu1, Mengyang Li2
1Department of Microbiology, College of Basic Medical Sciences, Key Laboratory of Microbial Engineering Under the Educational Committee in Chongqing, Army Medical University, Chongqing, 400038, China.
Abstract:
Gram-positive (G+) bacterial infection is a great burden to both healthcare and community medical resources. As a result of the increasing prevalence of multidrug-resistant G+ bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), novel antimicrobial agents must urgently be developed for the treatment of infections caused by G+ bacteria. Endolysins are bacteriophage (phage)-encoded enzymes that can specifically hydrolyze the bacterial cell wall and quickly kill bacteria. Bacterial resistance to endolysins is low. Therefore, endolysins are considered promising alternatives for solving the mounting resistance problem. In this review, endolysins derived from phages targeting G+ bacteria were classified based on their structural characteristics. The active mechanisms, efficacy, and advantages of endolysins as antibacterial drug candidates were summarized. Moreover, the remarkable potential of phage endolysins in the treatment of G+ bacterial infections was described. In addition, the safety of endolysins, challenges, and possible solutions were addressed. Notwithstanding the limitations of endolysins, the trends in development indicate that endolysin-based drugs will be approved in the near future. Overall, this review presents crucial information of the current progress involving endolysins as potential therapeutic agents, and it provides a guideline for biomaterial researchers who are devoting themselves to fighting against bacterial infections.
Insights
Endolysins, enzymes from bacteriophages, show promise as novel antibacterial agents against Gram-positive infections. Their low resistance potential offers a solution to multidrug-resistant bacteria.
Area of Science:
- Microbiology
- Biotechnology
- Infectious Diseases
Background:
- Gram-positive bacterial infections pose a significant healthcare burden.
- Rising multidrug-resistant strains like MRSA necessitate new antimicrobial strategies.
Purpose of the Study:
- To review endolysins derived from phages targeting Gram-positive bacteria.
- To summarize their mechanisms, efficacy, advantages, and potential as antibacterial drugs.
Main Methods:
- Classification of endolysins based on structural characteristics.
- Summary of published data on endolysin activity and safety.
- Discussion of challenges and future development trends.
Main Results:
- Endolysins specifically hydrolyze bacterial cell walls, leading to rapid bacterial death.
- Low incidence of bacterial resistance to endolysins.
- Phage endolysins demonstrate significant potential for treating Gram-positive infections.
Conclusions:
- Endolysins are promising therapeutic agents against Gram-positive bacterial infections.
- Despite limitations, ongoing development suggests future approval of endolysin-based drugs.
- This review provides insights for researchers developing novel antibacterial biomaterials.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
DNA Bacteriophages
Biological Methods for Microbial Control

